We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




New Technology for Isolating Pure RNA

By HospiMedica staff writers
Posted on 13 Mar 2006
A simple effective technology for isolating pure RNA from blood, animal tissue, or cultured cells has been developed. More...
The resultant RNA is essentially free of genomic DNA, protein, and other enzymatic inhibitors

Convenient, easy-to-use kits contain pre-mixed reagents, and samples can be processed at room temperature on the lab bench without a fume hood. There are no harsh organic solvents, foul-smelling agents, or reactive organic salts, eliminating the need for hazardous waste disposal. The sample preparation failure rate approaches zero, a great advantage for researchers working with precious samples.

Gentra (Minneapolis, MN, USA) introduced the new Versagene RNA purification system for Tempus blood collection tubes, which are produced by Applied Biosystems (Foster City, CA, USA). The Versagene chemistry was developed specifically to provide life sciences industries with a reliable and consistent method for obtaining pure RNA and DNA samples across a broad spectrum of sample types. Tempus blood RNA tubes are evacuated blood collection tubes that stabilize large quantities of RNA and expression profiles at room temperature.
The Versegene method, in tandem with Tempus blood collection tubes, provides a superior method for obtaining RNA for use in downstream applications, including RNA microarrays, quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) and real-time PCR.

"The Versegene RNA blood kits for Tempus tubes are ideally suited for isolating the high quality RNA required for highly sensitive assays used in the pharmacological and clinical diagnosis industries,” said Stephen Rundlett, Versagene product manager for Gentra. "Researchers can routinely obtain superior RNA yields with higher purity than what is obtained using other blood stabilization products.”

In addition to the Versagene RNA for blood for Tempus tubes kits, Gentra markets Versagene RNA purification kits for whole blood, cultured cells, tissue, and fibrous tissue, as well as DNA purification kits for whole blood and cultured cells.



Related Links:
Gentra
Applied Biosystems

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Hybrid Arch Device
Neo EDE
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.